Modern DLBCL Treatments: Smart Stop Trial | Jason Westin, MD | ASH 2023

Circulating Tumor DNA as a Detection Tool Following DLBCL Therapy | Mark Roschewski, MD | ASH 2023

PD-1 Blockade Pre-Transplant Improves Outcomes in Hodgkin Lymphoma

Treatment Locations for Young Adults with Aggressive B-Cell Lymphomas

Real-World Analysis in Refractory Hodgkin Lymphoma Patients

Advancement of Immunotherapy Treatment in Hodgkins Lymphoma

Drug study for Older Patients with Advanced Stage Hodgkin Lymphoma

ABBV-525 in CLL and Non-Hodgkin Lymphoma Patients

Predictors of CRS and Neurotoxicity in Lymphoma Patients

Loncastuximab for High-Risk Relapsed/Refractory FL | Juan Pablo Alderuccio, MD | ASH 2023

Trial of an Education Video for CAR T-cell Therapy Recipients

Fighting DLBCL by Attacking the Microenviroment | Leandro Cerchietti, MD | ASH 2023

Older Patients Experience Improved QOL with NHL Treatments

Moving Towards Immunotherapy for Newly Diagnosed DLBCL Patients | Paolo Strati, MD | ASH 2023